GALLIUM (GA67) CITRATE INJECTION SOLUTION
Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
Tabia za bidhaa
(SPC)
26-04-2019
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
GALLIUM CITRATE GA 67
Inapatikana kutoka:
CURIUM CANADA INC
ATC kanuni:
V09HX01
INN (Jina la Kimataifa):
GALLIUM 67 GA CITRATE
Kipimo:
74MBq
Dawa fomu:
SOLUTION
Tungo:
GALLIUM CITRATE GA 67 74MBq
Njia ya uendeshaji:
INTRAVENOUS
Vitengo katika mfuko:
15G/50G
Dawa ya aina:
Schedule C
Eneo la matibabu:
ROENTGENOGRAPHY
Bidhaa muhtasari:
Active ingredient group (AIG) number: 0152589005; AHFS:
Idhini hali ya:
APPROVED
Idhini ya tarehe:
2018-12-07
Tabia za bidhaa
_ _
_ _
_Page 1 of 15_
PRODUCT MONOGRAPH
GALLIUM (GA 67) CITRATE INJECTION
Gallium (Ga 67) Citrate
Solution, 74 MBq/mL
Radiodiagnostic agent
Curium Canada Inc.
2572 boul. Daniel-Johnson, Suite 245-249
Laval, QC, H7T-2R3
CANADA
Distributed by:
Curium Canada Inc.
Laval, QC, H7T-2R3
CANADA
Date of Revision: April 26
th
, 2019
CONTROL NO: 225104
_ _
_ _
_Page 2 of 15_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
SUMMARY PRODUCT INFORMATION
.......................................................................
3
DESCRIPTION...................................................................................................................
3
INDICATIONS AND CLINICAL USE
.............................................................................
5
CONTRAINDICATIONS
..................................................................................................
5
WARNINGS AND PRECAUTIONS
.................................................................................
5
ADVERSE REACTIONS
...................................................................................................
7
DRUG INTERACTIONS
...................................................................................................
7
DOSAGE AND ADMINISTRATION
...............................................................................
7
RADIATION DOSIMETRY
..............................................................................................
8
OVERDOSAGE
.................................................................................................................
9
ACTION AND CLINICAL PHARMACOLOGY
............................................................. 9
STORAGE AND STABILITY
.........................................................................................
10
SPECIAL HANDLING INSTRUCTIONS
......................................................................
10
DOSAGE FORMS, COMPOSITION AND PACKAGING
............................................ 10
Soma hati kamili
